This is a news story, published by Yahoo, that relates primarily to Iambic Therapeutics news.
For more tech startups news, you can click here:
more tech startups newsFor more news from Yahoo, you can click here:
more news from YahooOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best tech news, business news, entertainment news, and much more. If you like tech startups news, you might also like this article about
new AI drug discovery model. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest pharmaceutical research news, drug discovery pipeline news, tech startups news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Biotech firm Iambic TherapeuticsReuters
•81% Informative
Biotech firm Iambic Therapeutics unveils its new AI drug discovery model, named " Enchant " The model has been designed to predict how a given drug will perform at the earliest stage of development.
The company said its model set a new benchmark, with a 0.74 accuracy prediction score.
VR Score
91
Informative language
97
Neutral language
66
Article tone
semi-formal
Language
English
Language complexity
57
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links